Home/ Stocks/ IMRX

Immuneering Corporation Class A Common Stock

IMRX XNAS

$4.51 +0.05 (+1.12%) ▲ 15-min delayed

Open

$4.53

High

$4.57

Low

$4.43

Volume

720.3K

Market Cap

$288.55M

About Immuneering Corporation Class A Common Stock

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 57 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q2 2026	$0	$-17,270,427	$-0.27
Q1 2026	$0	$-13,460,895	$-0.21
FY 2025	$0	$-56,024,898	$-1.27
Q3 2025	$0	$-14,964,875	$-0.38

Related Market News

No specific coverage for IMRX yet. Check out our latest market news or earnings calendar.

Get IMRX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Immuneering Corporation Class A Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.